KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cal-Maine Foods (CALM) Cash & Equivalents (2016 - 2025)

Cal-Maine Foods (CALM) has disclosed Cash & Equivalents for 16 consecutive years, with $499.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Cash & Equivalents rose 109.94% to $499.4 million in Q2 2025 year-over-year; TTM through May 2025 was $499.4 million, a 109.94% increase, with the full-year FY2025 number at $499.4 million, up 109.94% from a year prior.
  • Cash & Equivalents was $499.4 million for Q2 2025 at Cal-Maine Foods, roughly flat from $497.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $499.4 million in Q2 2025 to a low of $15.5 million in Q4 2021.
  • A 5-year average of $227.2 million and a median of $229.7 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 67.27% in 2021, then skyrocketed 395.61% in 2023.
  • Cal-Maine Foods' Cash & Equivalents stood at $15.5 million in 2021, then soared by 281.58% to $59.1 million in 2022, then soared by 512.32% to $361.8 million in 2023, then plummeted by 34.25% to $237.9 million in 2024, then soared by 109.94% to $499.4 million in 2025.
  • Per Business Quant, the three most recent readings for CALM's Cash & Equivalents are $499.4 million (Q2 2025), $497.2 million (Q1 2025), and $237.9 million (Q2 2024).